Photo: Nadia Vetta Hamid for Coconuts Media" width="100%" />
Starting July 17, only those who have received a booster shot of a COVID-19 vaccine may bypass testing requirements for domestic travel, the Ministry of Transportation confirmed today.
The COVID-19 Task Force has published a new set of regulations regarding travel on all modes of transportation, which will come into effect next Sunday. A key point in the regulations is that travelers who have received three doses of a COVID-19 vaccine are not required to present a pre-departure negative PCR or antigen test result. Currently, travelers who have received at least two doses of a COVID-19 test are exempt from testing.
Children aged 6-17, an age group currently not eligible for booster shots, are exempt from testing if they have received two doses of a COVID-19 vaccine.
Children under 6, who are not yet eligible to receive any COVID-19 jabs, are exempt from all testing requirements but must be under constant supervision from their parents during the trip.
Adults with two doses of a COVID-19 vaccine must present a negative antigen test result obtained within one day from departure, or a negative PCR test result obtained within three days from departure.
Those with one dose must present a negative PCR test result obtained within three days from departure.
People who are unvaccinated may only travel if they obtain a medical note exempting them from COVID-19 jabs, as well as a negative PCR test result obtained within three days from departure.
There have been no updates yet to international travel rules. Under the COVID-19 Task Force’s latest set of regulations on international arrivals published in May, those who have received at least two doses of a COVID-19 vaccine and don’t exhibit symptoms related to the disease upon arrival may skip all testing requirements.
Indonesia has been tightening mobility curbs amid a steady increase in new COVID-19 infections in recent weeks. The country is expected to see a significant increase in infections in the third week of July due to the proliferation of the Omicron sub-variants BA.4 and BA.5.
